BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22126530)

  • 1. Bone remodeling-associated salivary biomarker MIP-1α distinguishes periodontal disease from health.
    Al-Sabbagh M; Alladah A; Lin Y; Kryscio RJ; Thomas MV; Ebersole JL; Miller CS
    J Periodontal Res; 2012 Jun; 47(3):389-95. PubMed ID: 22126530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone remodeling biomarkers of periodontal disease in saliva.
    Frodge BD; Ebersole JL; Kryscio RJ; Thomas MV; Miller CS
    J Periodontol; 2008 Oct; 79(10):1913-9. PubMed ID: 18834246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease?
    Fine DH; Markowitz K; Furgang D; Fairlie K; Ferrandiz J; Nasri C; McKiernan M; Donnelly R; Gunsolley J
    J Periodontol; 2009 Jan; 80(1):106-13. PubMed ID: 19228096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary osteocalcin levels are decreased in smoker chronic periodontitis patients.
    Ozçaka O; Nalbantsoy A; Buduneli N
    Oral Dis; 2011 Mar; 17(2):200-5. PubMed ID: 20796231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of salivary levels of mucin and amylase in chronic periodontitis patients.
    Sánchez GA; Miozza V; Delgado A; Busch L
    J Periodontal Res; 2011 Apr; 46(2):221-7. PubMed ID: 21143482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?
    Glimvall P; Wickström C; Jansson H
    J Periodontal Res; 2012 Oct; 47(5):655-60. PubMed ID: 22471324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rheumatoid arthritis and salivary biomarkers of periodontal disease.
    Mirrielees J; Crofford LJ; Lin Y; Kryscio RJ; Dawson DR; Ebersole JL; Miller CS
    J Clin Periodontol; 2010 Dec; 37(12):1068-74. PubMed ID: 20880053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
    Kaushik R; Yeltiwar RK; Pushpanshu K
    J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary malondialdehyde levels in clinically healthy and periodontal diseased individuals.
    Khalili J; Biloklytska HF
    Oral Dis; 2008 Nov; 14(8):754-60. PubMed ID: 18665859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary biomarkers associated with gingivitis and response to therapy.
    Syndergaard B; Al-Sabbagh M; Kryscio RJ; Xi J; Ding X; Ebersole JL; Miller CS
    J Periodontol; 2014 Aug; 85(8):e295-303. PubMed ID: 24502627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-related protein (MRP8/14) expression in gingival crevice fluid in periodontal health and disease and after treatment.
    Andersen E; Dessaix IM; Perneger T; Mombelli A
    J Periodontal Res; 2010 Aug; 45(4):458-63. PubMed ID: 20337885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-telopeptide pyridinoline crosslinks of type I collagen, soluble RANKL, and osteoprotegerin levels in crevicular fluid of dental implants with peri-implantitis: a case-control study.
    Arikan F; Buduneli N; Lappin DF
    Int J Oral Maxillofac Implants; 2011; 26(2):282-9. PubMed ID: 21483881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary IL-1β and PGE2 as biomarkers of periodontal status, before and after periodontal treatment.
    Sánchez GA; Miozza VA; Delgado A; Busch L
    J Clin Periodontol; 2013 Dec; 40(12):1112-7. PubMed ID: 24118119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between salivary leukotriene B4 levels and salivary mucin or alveolar bone resorption, in subjects with periodontal health and disease.
    Sánchez GA; Miozza VA; Delgado A; Busch L
    J Periodontal Res; 2013 Dec; 48(6):810-4. PubMed ID: 23488687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary visfatin concentrations in patients with chronic periodontitis.
    Tabari ZA; Azadmehr A; Nohekhan A; Naddafpour N; Ghaedi FB
    J Periodontol; 2014 Aug; 85(8):1081-5. PubMed ID: 24228809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole salivary interleukin-6 and matrix metalloproteinase-8 levels in patients with chronic periodontitis with and without prediabetes.
    Javed F; Ahmed HB; Saeed A; Mehmood A; Bain C
    J Periodontol; 2014 May; 85(5):e130-5. PubMed ID: 24171502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary infectious agents and periodontal disease status.
    Saygun I; Nizam N; Keskiner I; Bal V; Kubar A; Açıkel C; Serdar M; Slots J
    J Periodontal Res; 2011 Apr; 46(2):235-9. PubMed ID: 21261620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of salivary procalcitonin levels in different periodontal diseases.
    Hendek MK; Erdemir EO; Kisa U
    J Periodontol; 2015 Jun; 86(6):820-6. PubMed ID: 25703733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between pentraxin 3 or cytokine levels in gingival crevicular fluid and clinical parameters of chronic periodontitis.
    Fujita Y; Ito H; Sekino S; Numabe Y
    Odontology; 2012 Jul; 100(2):215-21. PubMed ID: 21932007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary biomarkers of periodontal disease in response to treatment.
    Sexton WM; Lin Y; Kryscio RJ; Dawson DR; Ebersole JL; Miller CS
    J Clin Periodontol; 2011 May; 38(5):434-41. PubMed ID: 21480939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.